
Steve brings 20+ years in pharma and biotech, from launching therapies at Novo Nordisk and J&J to leading Provell Pharma, with $50M+ impact. Backed by an extensive network, he helps teams align people, systems, and processes to turn strategy into action, all while helping bring therapies to patients faster.
CatalysRX Consulting, LLC
210 Crossings Blvd | PMB-219 | Elverson, PA 19520